Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma

• Michael K. Kiessling ,

  * E-mail: Michael.kiessling@usz.ch

  Affiliations Department of Gastroenterology and Hepatology, UniversityHospital Zurich, Zurich, Switzerland, Department of Oncology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Alessandra Curioni-Fontecedro,

  Affiliation Department of Oncology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Panagiotis Samaras,

  Affiliation Department of Oncology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Silvia Lang,

  Affiliation Department of Gastroenterology and Hepatology, UniversityHospital Zurich, Zurich, Switzerland

  ⨯
• Michael Scharl,

  Affiliation Department of Gastroenterology and Hepatology, UniversityHospital Zurich, Zurich, Switzerland

  ⨯
• Adriano Aguzzi,

  Affiliation Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Derek A. Oldrige,

  Affiliation Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, United States of America

  ⨯
• John M. Maris,

  Affiliation Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, United States of America

  ⨯
• Gerhard Rogler

  Affiliation Department of Gastroenterology and Hepatology, UniversityHospital Zurich, Zurich, Switzerland

  ⨯